Saltar para o conteúdo
Radio Logo
PodcastsCiênciaAI in Medicine - curated summaries making complex issues easy to understand

AI in Medicine - curated summaries making complex issues easy to understand

Mike Rawson
Último episódio

181 episódios

  • AI in Medicine - curated summaries making complex issues easy to understand

    Company Spotlight: Us2.ai Us2.ca - AI Detection for Cardiac Amyloidosis

    19/11/2026 | 12min
    We unpack the FDA 510(k) summary for Us2.ca, an AI software device by Us2.ai designed to detect cardiac amyloidosis from echocardiograms. We break down the clinical testing data, demographic performance differences, and key limitations hospital buyers need to know.

    Key points

    Us2.ca is cleared via the FDA 510(k) pathway as substantially equivalent to the predicate device, EchoGo Cardiac Amyloidosis 1.0.
    The software is indicated for adult patients with a specific left ventricular wall thickness of ≥ 12mm.
    In retrospective testing of 1,647 patients, the device produced a confident prediction for 1434 patients, yielding an 87.1% success rate.
    Performance on the confident predictions showed an overall sensitivity of 86.9% and specificity of 87.4%.
    The summary outlines strict limitations: it does not provide a diagnosis, does not highlight regions of interest on the image, and was only externally validated on GE and Philips ultrasound systems.

    Source: FDA 510(k) summary K250151: Us2.ca (Eko.Ai Pte) - U.S. Food and Drug Administration, 2025

    This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

    Company: Eko.Ai Pte · Product: Us2.ca · FDA 510(k) K250151

    Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-us2-ai-us2-ca-ai-detection-for-cardiac-amyloidosis-67a2d8
  • AI in Medicine - curated summaries making complex issues easy to understand

    When Clinical AI Acts on Its Own: Building Defensible Agents in Healthcare

    19/11/2026 | 19min
    AI in healthcare is shifting from making predictions to taking autonomous actions. This document from IQVIA outlines how health systems and pharma companies must update their validation pipelines to ensure AI agents are defensible, auditable, and safe.

    Key points

    The software landscape has entered the agentic era, where AI no longer just drafts code or predicts outcomes, but actively takes actions like querying databases and updating records.
    Regulators have shifted their stance in just 24 months, moving from basic trustworthiness to requiring provable, continuous evidence of an AI system's safety and reliability.
    Risk tiering must be driven by the specific use case and downstream impact, with the autonomy of the agent acting as the primary amplifier of risk.
    Validating agents requires evaluating the entire dynamic workflow and how errors compound, not just testing an underlying model's accuracy on a static dataset.
    To govern autonomous systems at scale, organizations must use AI agents to validate other agents, while keeping humans accountable for the final judgment and acceptance criteria.
    Under Article 4 of the EU AI Act, AI literacy is no longer just an HR initiative, but a mandatory market-access requirement for everyone interacting with these systems.

    Source: Validating AI Agents and Software - IQVIA, 2026

    This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

    This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

    Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/when-clinical-ai-acts-on-its-own-building-defensible-agents-in-healthc-d453a3
  • AI in Medicine - curated summaries making complex issues easy to understand

    Company Spotlight: DigestAID Deep Capsule - Sifting Millions of Frames for GI Bleeds

    18/11/2026 | 13min
    DigestAID recently secured FDA 510(k) clearance for Deep Capsule, an AI tool designed to help gastroenterologists review capsule endoscopy footage for small bowel bleeding. Maya and Sam unpack the clearance summary to explore the algorithm's performance data, its substantial equivalence to a predicate device, and the real-world trade-offs between high sensitivity and low specificity when reviewing millions of video frames.

    Key points

    Deep Capsule is an AI software that acts as a computer-aided detection tool to help reviewers spot potential small bowel lesions in adults, outputting suspected frames into a thumbnail gallery.
    The FDA 510(k) clearance is based on substantial equivalence to the NaviCam ProScan, though Deep Capsule does not identify the anatomical location of the digestive tract like its predicate does.
    In a retrospective clinical validation study of 330 patients, AI-assisted reading achieved a diagnostic yield of 0.961, compared to 0.761 for standard-of-care reading.
    Patient-level sensitivity jumped from 0.762 with standard reading to 0.972 with AI assistance, but clinical specificity was notably low at 0.125 for the AI arm.
    The software was heavily tested on the PillCam SB3 system, which accounted for 307 of the 330 clinical validation exams, meaning compatibility should be checked before procurement.

    Source: FDA 510(k) summary K250655: Deep Capsule® (Deep Capsule US) (Digestaid - Artificial Intelligence Development) - U.S. Food and Drug Administration, 2026

    This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

    Company: Digestaid - Artificial Intelligence Development (digestaid.health) · Product: Deep Capsule® (Deep Capsule US) · FDA 510(k) K250655

    Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-digestaid-deep-capsule-sifting-millions-of-frames-fo-e5081f
  • AI in Medicine - curated summaries making complex issues easy to understand

    Why Do Imaging Algorithms Stall? Deskilling, Friction, and AI's Workforce Problem

    18/11/2026 | 16min
    Health systems are eager to deploy diagnostic AI to boost speed and accuracy, but a new systematic review reveals a massive blind spot: human adaptation. We unpack why high-performing algorithms face workforce resistance, exploring fears of deskilling, loss of autonomy, and mental strain. Discover what the evidence says about building a sustainable, AI-equipped clinical team.

    Key points

    A systematic review of 69 peer-reviewed articles found that while 54% of studies show AI improves reading times and accuracy, health systems severely neglect post-adoption workforce adaptation.
    Fears of job displacement are overshadowed by deskilling anxiety, loss of professional autonomy, and concerns over legal liability, which were highlighted in 36% of the reviewed literature.
    Trust is a critical bottleneck: 41% of studies centered on workforce confidence in AI outputs, emphasizing that clinicians must be able to understand and easily override algorithm decisions.
    The existing evidence base is methodologically skewed: 73.91% of studies use quantitative designs to measure initial acceptance, while long-term cognitive and behavioral adaptations remain poorly understood.
    To achieve long-term workforce sustainability, the literature indicates health systems desperately need structured training programs, clear organizational policies, and compliance guidelines, which are currently lacking.

    Source: AI Adoption, Adaptation, and Workforce Sustainability in Medical Imaging: Systematic Review and Conceptual Framework - JMIR AI, 2026 (CC BY)

    This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

    This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

    Authors: Paula Brough, Khondker Mohammad Zobair, Javad Pool, Natalie Haskell, Luke Houghton, Paul Scuffham et al. · DOI: 10.2196/101944

    Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/why-do-imaging-algorithms-stall-deskilling-friction-and-ai-s-workforce-6aaf06
  • AI in Medicine - curated summaries making complex issues easy to understand

    Why One-Time Bias Checks Fail: Building Continuous AI Audit Pipelines in Healthcare

    17/11/2026 | 14min
    This episode unpacks a scoping review on operationalizing fair AI in healthcare, focusing on why static pre-deployment bias checks are no longer enough. Maya and Sam explore the transition to continuous monitoring, detailing specific bias mitigation strategies, the complexities of regulatory compliance, and the exact tools organizations are using to build ongoing algorithmic audit pipelines.

    Key points

    AI Act certification compliance is estimated to cost between 10 to 14% of development costs, highlighting the massive operational burden of AI governance.
    A review of 66 studies reveals that fairness in healthcare AI requires a shift from static, one-time checks to continuous post-deployment monitoring due to risks like fairness drifts.
    Technical bias mitigation spans multiple lifecycle stages, utilizing methods like the Synthetic Minority Oversampling Technique, Generative Adversarial Networks, and adversarial debiasing.
    Only 54% of surveyed WHO Member States reported having regulatory agencies responsible for assessing and approving health AI, exposing a global gap in post-deployment surveillance.
    Effective AI governance demands a multidisciplinary approach, utilizing specific auditing toolkits like IBM's AI Fairness 360 and explainable AI models to maintain safety and compliance.

    Source: Operationalizing fair AI in healthcare: a scoping review of bias mitigation, monitoring, auditing, and governance strategies - Frontiers in digital health, 2026 (CC BY)

    This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

    This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

    Authors: Ana Teresa Rebocho, Sara Silva Marques, João Pedro Santos, Cátia Sousa Pinto · DOI: 10.3389/fdgth.2026.1888744

    Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/why-one-time-bias-checks-fail-building-continuous-ai-audit-pipelines-i-9e2c43
Mais podcasts de Ciência
Sobre AI in Medicine - curated summaries making complex issues easy to understand
AI in Medicine - Smart Summaries is a daily podcast for clinicians, health-system leaders and medtech, pharma and digital-health teams. Each episode unpacks one important public document on artificial intelligence in healthcare, such as FDA, EMA, MHRA, WHO or NHS guidance, OECD and World Economic Forum reports, or an open-access peer-reviewed review, in a clear 15 to 20 minute conversation. Topics include clinical AI and decision support, medical imaging and radiology AI, large language models (LLMs) and generative AI in clinical practice, AI-enabled medical devices and their regulation, the EU AI Act, drug discovery and clinical trials, digital health and wearables, health-system adoption, patient safety, bias and liability. The source of every episode is linked in the show notes, and full transcripts are at ai-in-medicine-podcast.vercel.app. The hosts' voices are AI-generated. For information only, not medical advice.
Sítio Web de podcast

Ouve AI in Medicine - curated summaries making complex issues easy to understand, The Rest Is Science e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
AI in Medicine - curated summaries making complex issues easy to understand: Podcast do grupo